Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 41 announcements

Share price
₹1,146.30
Market cap
₹15,904 Cr
Revenue (annual)
₹3,129 Cr
Net profit (annual)
₹619.5 Cr
P/E (TTM)
24.7×Sector 47.4×
Promoter holding
54.14%+0.22% QoQ
FII holding
5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

09:09 IST NSE
Management Change

Eris Lifesciences Management Change

Eris Lifesciences appointed Mr. Akhil Awasthi as Non-Executive Independent Director effective September 26, 2026 for a five-year term, subject to shareholder approval. No monetary value is associated with the appointment.

16:09 IST NSE
Management Change

Eris Lifesciences Management Change

Mr. Krishnakumar Vaidyanathan has resigned as Executive Director and Chief Operating Officer of Eris Lifesciences Limited, effective September 30, 2026.

11:13 IST BSE
Management Change

Eris Lifesciences Management Change

Eris Lifesciences Limited's board approved the re-appointment of Mr. Sujesh Vasudevan as an Independent Director. The company also scheduled its 20th Annual General Meeting for September 25, 2026.

Execution
5 Years